medRxivGenetic & Genomic MedicinePreprint
Disruption of the topological associated domain at Xp21.2 is related to gonadal dysgenesis: A general mechanism of pathogenesis
Ana Paula SantosiD, Jakob A. Meinel, Cristiane S.C. PivetaiD, Juliana Gabriel Ribeiro de AndradeiD, Helena Fabbri‐ScalletiD, Vera Lúcia Gil‐da‐Silva‐LopesiD, Gil Guerra‐JúnioriD, Axel KünstneriD, Frank J. Kaiser, Paul‐Martin HolterhusiD, Olaf HiortiD, Hauke S. BuschiD, Andréa Trevas Maciel‐GuerraiD, Maricilda Palandi de MelloiD, Ralf WerneriD
Abstract
Duplications of dosage sensitive sex-locus Xp21.2 including NR0B1 have been linked to 46,XY gonadal dysgenesis (GD) and their effects are attributed merely to increase gene dosage of NR0B1 (DAX1). Here we present a general mechanism how deletions, duplications, triplications or inversions with or without NR0B1 at Xp21.2 can lead to partial or complete GD by disrupting the cognate topological associated domain (TAD) in the vincinity of NR0B1. Our model is supported by three unrelated patients: two showing a 287kb overlapping duplication at the Xp21.2 locus upstream of NR0B1 containing CXorf21 and GK and one patient having a large new triplication of Xp21.2 as the most likely cause of GD. Whole Genome sequencing uncovered the exact structural rearrangements of the duplications and the triplication. Comparison with a previously published deletion upstream of NR0B1 revealed a common 35kb overlap between the deletion, our newly reported NR0B1 upstream duplications and the triplication as well as all other copy number variations (CNVs) at Xp21.2 reported so far. This overlap contains a strong CCCTC-binding factor (CTCF) binding site representing one boundary of the NR0B1 TAD. All three CNVs at Xp21.2 most likely disrupt this TAD boundary, which isolates NR0B1 from CXorf21 and GK and putatively results in GK and CXorf21 enhancer adoption and ensuing ectopic NR0B1 expression. As a result, the patients transcriptomes developed an intermediate expression pattern with both ovarian and testicular features and greatly reduced expression of spermatogenesis-related genes. This model not only allows better diagnosis of GD displaying CNVs at Xp21.2, but also gives deeper insight how spatiotemporal activation of developmental genes can be disrupted by reorganized TADs also in other rare diseases.
- organism: human
- assay: whole-genome sequencing
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: variant calling
- approach: statistical model
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Increased Expression of ZFPM2 Bypasses SRY to Drive 46,XX Testicular Development: A New Mechanism of 46,XX DSD
Leah Ragno, Daphne Yang, … Louise C. Pyle·medRxiv·May 27, 2024
- A conserved regulatory atlas reveals enhancers critical for mouse and human gonadal development
Aviva Eliyahu, Ido Blass, … Nitzan Gonen·medRxiv·Jul 13, 2026
- DEAH-box helicase 37 (DHX37) defects are a novel molecular etiology of 46,XY gonadal dysgenesis spectrum
Thatiana Evilen da Silva, Nathália Lisboa Gomes, … Sorahia Domenice·bioRxiv·Dec 10, 2018
- Evidence for NR2F2/COUP-TFII involvement in human testis development
Somboon Wankanit, Housna Zidoune, … Maëva Elzaïat·bioRxiv·Jan 5, 2024
- Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly
Tatsiana Aneichyk, William T. J. Hendriks, … Michael E. Talkowski·CellPeer-reviewed·Jan 1, 2018
- Nucleoporin107 mediates female sexual differentiation via Dsx
Tikva Shorê, Tgst Levi, … Offer Gerlitz·eLifePeer-reviewed·Mar 21, 2022